Metraipolis › archive › dc_d020e468bc27

Advances in Targeting Central Cholinergic Dysfunction for Neurodegenerative Diseases: From Pharmacotherapy to Neuromodulation — Europe PMC PMID:42723527

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42723527
DOI
10.1002/cns.71151
License (as archived)
solo-consultazione
Archived
2026-10-16T07:10:22.869Z
SHA-256 of the archived text
690e6e736d6b9dffcdbbeb563453e928fd182625990cf3d31e35c77d7a1a4a9b
Stable URL of this page
https://metraipolis.com/documento/dc_d020e468bc27

How to cite

Advances in Targeting Central Cholinergic Dysfunction for Neurodegenerative Diseases: From Pharmacotherapy to Neuromodulation — Europe PMC PMID:42723527 — Europe PMC (en), https://europepmc.org/article/MED/42723527 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_d020e468bc27 (Metraipolis archive dc_d020e468bc27, sha256 690e6e736d6b9dffcdbbeb563453e928fd182625990cf3d31e35c77d7a1a4a9b)
BibTeX
@misc{dcd020e468bc27,
  title = {Advances in Targeting Central Cholinergic Dysfunction for Neurodegenerative Diseases: From Pharmacotherapy to Neuromodulation — Europe PMC PMID:42723527},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42723527},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_d020e468bc27; sha256 690e6e736d6b9dffcdbbeb563453e928fd182625990cf3d31e35c77d7a1a4a9b},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42723527. Agents can read the archived copy with the MCP tool read_document.